171 related articles for article (PubMed ID: 33686019)
1. Potential role of glucosamine-phosphate N-acetyltransferase 1 in the development of lung adenocarcinoma.
Zhang S; Zhang H; Li H; Guo J; Wang J; Zhang L
Aging (Albany NY); 2021 Mar; 13(5):7430-7453. PubMed ID: 33686019
[TBL] [Abstract][Full Text] [Related]
2. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.
Zheng X; Li Y; Ma C; Zhang J; Zhang Y; Fu Z; Luo H
Biomed Res Int; 2020; 2020():8851437. PubMed ID: 33178836
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of glucosamine-phosphate N-acetyltransferase 1 is a promising diagnostic and predictive indicator for poor survival in patients with lung adenocarcinoma.
Zhu P; Gu S; Huang H; Zhong C; Liu Z; Zhang X; Wang W; Xie S; Wu K; Lu T; Zhou Y
Oncol Lett; 2021 Jun; 21(6):488. PubMed ID: 33968204
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine-phosphate N-acetyltransferase 1 and its DNA methylation can be biomarkers for the diagnosis and prognosis of lung cancer.
Ding P; Peng B; Li G; Sun X; Wang G
J Clin Lab Anal; 2022 Sep; 36(9):e24628. PubMed ID: 35929347
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma.
Liu W; Jiang K; Wang J; Mei T; Zhao M; Huang D
Front Mol Biosci; 2021; 8():605754. PubMed ID: 33842535
[TBL] [Abstract][Full Text] [Related]
6. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
[TBL] [Abstract][Full Text] [Related]
7. Novel form of rhizomelic skeletal dysplasia associated with a homozygous variant in
Ain NU; Baroncelli M; Costantini A; Ishaq T; Taylan F; Nilsson O; Mäkitie O; Naz S
J Med Genet; 2021 May; 58(5):351-356. PubMed ID: 32591345
[TBL] [Abstract][Full Text] [Related]
8. GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker.
Hu H; Wang ZW; Hu S; Xiang Y; Deng Y; Wan FJ; Zhang TC; Yang ZY; Liao XH
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37387422
[TBL] [Abstract][Full Text] [Related]
9. GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer.
Feng Y; Li N; Ren Y
Cancer Manag Res; 2022; 14():2419-2428. PubMed ID: 35975106
[TBL] [Abstract][Full Text] [Related]
10. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
[TBL] [Abstract][Full Text] [Related]
11. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
13. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression.
Liu Y; Xie P; Jiang D; Liu J; Zhang J; Bian T; Shi J
Front Immunol; 2020; 11():568440. PubMed ID: 33424830
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
16. Tectoridin and PLK1 inhibitor synergistically promote the apoptosis of lung adenocarcinoma cells: Bioinformatic analysis of TCGA and TCMSP.
Wang M; Zhao F; Li Z; Li X; Dong L
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2417-2426. PubMed ID: 37014402
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide analysis of the hypoxia-related DNA methylation-driven genes in lung adenocarcinoma progression.
Li H; Tong L; Tao H; Liu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32031203
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1/GNA1).
Zhao M; Li H; Ma Y; Gong H; Yang S; Fang Q; Hu Z
Int J Nanomedicine; 2017; 12():1685-1697. PubMed ID: 28280335
[TBL] [Abstract][Full Text] [Related]
19. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
20. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
